Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.
FASEB J. 2020 Dec;34(12):15630-15646. doi: 10.1096/fj.202001951R. Epub 2020 Oct 15.
Long noncoding RNAs (lncRNAs) have emerged as key regulators in a variety of cellular processes that influence disease states. In particular, many lncRNAs are genetically or epigenetically deregulated in cancer. However, whether lncRNA alterations are passengers acquired during cancer progression or can act as tumorigenic drivers is a topic of ongoing investigation. In this review, we examine the current methodologies underlying the identification of cancer-associated lncRNAs and highlight important considerations for evaluating their biological significance as cancer drivers.
长链非编码 RNA(lncRNA)已成为影响疾病状态的多种细胞过程中的关键调节因子。特别是,许多 lncRNA 在癌症中存在遗传或表观遗传失调。然而,lncRNA 的改变是在癌症进展过程中获得的乘客改变,还是可以作为致癌驱动因素发挥作用,这是一个正在研究的课题。在这篇综述中,我们检查了目前鉴定与癌症相关的 lncRNA 的方法,并强调了评估它们作为癌症驱动因素的生物学意义的重要考虑因素。